An Open-Label Study in Adolescent and Adult Severe (Coagulation Factor Activity <1%) Hemophilia A or B Patients With or Without Inhibitors Comparing Standard Treatment to PF-06741086 Prophylaxis
2022-06-29
عنوان الدراسة
An Open-Label Study in Adolescent and Adult Severe (Coagulation Factor Activity <1%) Hemophilia A or B Patients With or Without Inhibitors Comparing Standard Treatment to PF-06741086 Prophylaxis
داعم الدراسة
Pfizer
دواء الدراسة
PF-06741086
رقم بروتوكول الدراسة
B7841005
حالة الدراسة
Ongoing
موقع الدراسة
King Abdulaziz University Hospital (Jeddah)
مرحلة الدراسة
3
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.